Prazosin as an Adjuvant to Increase Effectiveness of Duloxetine in a Rat Model of Oxaliplatin-Induced Peripheral Neuropathy

Authors
Monica A. Wagner, Ellen M. Lavoie Smith, Naji Ayyash, Janean E. Holden


Lab

Journal
Seminars in Oncology Nursing

Abstract
Duloxetine, the only American Society of Clinical Oncology (ASCO) treatment recommended for chemotherapy-induced peripheral neuropathy (CIPN) in cance

Keywords/Topics
prazosin;adjuvant;increase;effectiveness;duloxetine;model;oxaliplatin-induced;peripheral;neuropathy;american

BIOSEB Instruments Used:
Von Frey Filaments (BIO-VF-M)

Source :

https://www.sciencedirect.com/science/article/pii/S0749208124001487

Related products

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.